Skip to main content
Erschienen in: Techniques in Coloproctology 1/2011

01.10.2011

General principles of hepatectomy in colorectal liver metastases

verfasst von: I. Maroulis, D. D. Karavias, D. Karavias

Erschienen in: Techniques in Coloproctology | Sonderheft 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Hepatic resection for colorectal liver metastases remains the only therapeutic option that improves long-term survival and offers potential cure. By conventional resectability criteria, only a limited number of patients with metastatic disease can be subjected to surgical intervention. In the past decade, better understanding of the natural history of the disease, the introduction of new chemotherapy agents and the advances in surgical techniques have led to more patients being eligible for surgery. Neoadjuvant chemotherapy can reduce the size of the metastases, allowing operation on patients who were previously considered inoperable. Major resections can nowadays be safely performed with the development of new less-invasive techniques and with the use of supplementary tools like ablation techniques. Using portal vein embolization to induce hypertrophy of future liver remnant and combining it with two-staged hepatectomy allow more patients with advanced disease to undergo potentially curative surgery. Careful selection of patients and aggressive surgery in experienced centers improve survival rates.
Literatur
1.
Zurück zum Zitat Kemeny N (2010) The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol 22:364–373PubMedCrossRef Kemeny N (2010) The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol 22:364–373PubMedCrossRef
2.
Zurück zum Zitat Yang AD, Brouquet A, Vauthey JN (2010) Extending limits of resection for metastatic colorectal cancer: risk benefit ratio. J Surg Oncol 102:996–1001PubMedCrossRef Yang AD, Brouquet A, Vauthey JN (2010) Extending limits of resection for metastatic colorectal cancer: risk benefit ratio. J Surg Oncol 102:996–1001PubMedCrossRef
3.
Zurück zum Zitat Van den Eynde M, Hendlisz A (2009) Treatment of colorectal liver metastases: a review. Rev Recent Clin Trials 4(1):56–62PubMedCrossRef Van den Eynde M, Hendlisz A (2009) Treatment of colorectal liver metastases: a review. Rev Recent Clin Trials 4(1):56–62PubMedCrossRef
4.
Zurück zum Zitat Charnsangavej C, Clary B, Fong Y et al (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1261–1268PubMedCrossRef Charnsangavej C, Clary B, Fong Y et al (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1261–1268PubMedCrossRef
5.
Zurück zum Zitat Vauthey JN, Chaoui A, Do KA et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512–519PubMedCrossRef Vauthey JN, Chaoui A, Do KA et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512–519PubMedCrossRef
6.
Zurück zum Zitat Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1,568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262PubMedCrossRef Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1,568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262PubMedCrossRef
7.
Zurück zum Zitat Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg 230:309–318PubMedCrossRef Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg 230:309–318PubMedCrossRef
8.
Zurück zum Zitat Elias D, Liberale G, Vernerey D et al (2005) Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12:900–909PubMedCrossRef Elias D, Liberale G, Vernerey D et al (2005) Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12:900–909PubMedCrossRef
9.
Zurück zum Zitat Jaeck D, Nakano H, Bachellier P et al (2002) Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 9:430–438PubMedCrossRef Jaeck D, Nakano H, Bachellier P et al (2002) Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 9:430–438PubMedCrossRef
10.
Zurück zum Zitat Lochan R, White SA, Manas DM (2007) Liver resection for colorectal liver metastasis. Surg Oncol 16:33–45PubMedCrossRef Lochan R, White SA, Manas DM (2007) Liver resection for colorectal liver metastasis. Surg Oncol 16:33–45PubMedCrossRef
11.
Zurück zum Zitat Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–3683PubMedCrossRef Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677–3683PubMedCrossRef
12.
Zurück zum Zitat Couinad C, Delmas A, Penna C et al (1957) Le foie: etudes anatomiques et chirurgicales. Masson, Paris Couinad C, Delmas A, Penna C et al (1957) Le foie: etudes anatomiques et chirurgicales. Masson, Paris
13.
Zurück zum Zitat Bismuth H, Adam R, Lévi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–602PubMedCrossRef Bismuth H, Adam R, Lévi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–602PubMedCrossRef
14.
Zurück zum Zitat Kinoshita H, Sakai K, Hirohashi K (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10:803–808PubMedCrossRef Kinoshita H, Sakai K, Hirohashi K (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10:803–808PubMedCrossRef
15.
Zurück zum Zitat Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945PubMedCrossRef Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945PubMedCrossRef
16.
Zurück zum Zitat Adam R, Hoti E, Bredt LC (2010) Evolution of neoadjuvant therapy for extended hepatic metastases-have we reached our [non-resectable] limit? J Surg Oncol 102:922–931PubMedCrossRef Adam R, Hoti E, Bredt LC (2010) Evolution of neoadjuvant therapy for extended hepatic metastases-have we reached our [non-resectable] limit? J Surg Oncol 102:922–931PubMedCrossRef
17.
Zurück zum Zitat Chun YS, Vauthey JN, Ribero D et al (2007) Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11:1498–1504PubMedCrossRef Chun YS, Vauthey JN, Ribero D et al (2007) Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11:1498–1504PubMedCrossRef
18.
Zurück zum Zitat Berber E, Tsinberg M, Tellioglu G et al (2008) Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg 12:1967–1972PubMedCrossRef Berber E, Tsinberg M, Tellioglu G et al (2008) Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg 12:1967–1972PubMedCrossRef
19.
Zurück zum Zitat Pessaux P, Lermite E, Brehant O et al (2006) Repeat hepatectomy for recurrent colorectal liver metastases. J Surg Oncol 93:1–7PubMedCrossRef Pessaux P, Lermite E, Brehant O et al (2006) Repeat hepatectomy for recurrent colorectal liver metastases. J Surg Oncol 93:1–7PubMedCrossRef
Metadaten
Titel
General principles of hepatectomy in colorectal liver metastases
verfasst von
I. Maroulis
D. D. Karavias
D. Karavias
Publikationsdatum
01.10.2011
Verlag
Springer Milan
Erschienen in
Techniques in Coloproctology / Ausgabe Sonderheft 1/2011
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-011-0750-0

Weitere Artikel der Sonderheft 1/2011

Techniques in Coloproctology 1/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.